Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04289779
Title Study of CAbozantinib in Combination With AtezolizumaB for Muscle-Invasive BladdEr Cancer (ABATE) (ABATE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Deepak Kilari
Indications

bladder urothelial carcinoma

Therapies

Atezolizumab + Cabozantinib

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
John Theurer Cancer Center Recruiting Hackensack New Jersey 07601 United States Details
University of Rochester Medical Center Recruiting Rochester New York 14642 United States Details
Vanderbilt-Ingram Cancer Center Recruiting Nashville Tennessee 37232 United States Details
Froedtert and The Medical College of Wisconsin Recruiting Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field